Active	Status	Sponsor type	Region	Phase	Filter
1 Active 4 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
PINOTTI, GRAZIELLA
I-Tackle, NCT03666325: Immunotherapy +/- EGFR Inhibitor In Advanced/Metastatic cSCC: Tackling Primary And Secondary Resistance	Not yet recruiting	2	43	Europe	Pembrolizumab, Keytruda, Cetuximab, Erbitux	Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Merck Sharp & Dohme LLC	Skin Neoplasm	10/20	10/22